Stockholm, August 17th 2022 - Intervacc AB (publ) announces today that Strangvac® is now available for sale in the UK.
This week Strangvac® has been launched in ... Read more
Stockholm, July 26, 2022 - Intervacc AB (publ) (First North: IVACC) ("Intervacc") announces today that the CEO, Andreas Andersson, together with three other key persons, has subscribed for 330,455 shares through the ... Read more
Stockholm, July 20th 2022 - Intervacc AB (publ) announces today that the company has received an order for the equivalent of approximately SEK 3 million from Dechra. The order concerns the delivery of ... Read more
Stockholm, July 20th, 2022 - Intervacc AB (publ) announces today that the first batch of Strangvac® for sale in the UK has been released.
Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Tuesday 14 June 2022, at which the following resolutions were made.
Stockholm, May 31, 2022 - Intervacc announces today that Strangvac®, a vaccine against the highly contagious infectious disease equine strangles, has been released for sale in Denmark.
